Plozasiran reduces triglyceride levels by 74% at 24 weeks

In patients with severely elevated triglyceride levels at risk for developing acute pancreatitis, the investigational drug plozasiran reduced triglyceride levels by an average of 74% after 24 weeks of use without causing ...

Obstetrics & gynaecology

Managing menopause: Hormone therapy is back

Hot flashes, night sweats and sleep disturbances are common symptoms of menopause that can affect health, quality of life and work productivity. A new review published in the Canadian Medical Association Journal (CMAJ ) recommends ...

page 1 from 16